検索結果

, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less than 0...

, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less than 0...

, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less than 0...

ess. In Japan, glaucoma is reported to be the leading cause of visual impairment (including reduced vision and blindness) affecting one in Japanese over the age of 402. The visual impairment caused by...

信息 | 关于千寿 | 千寿制药株式会社

护这些价值观，同时继续成为一家有价值的企业，我们始终积极向上、挑战、并不断变化。 我们希望通过持续创造并提供革新性医药产品与服务，对维持和提升世界各地患者的“视觉喜悦”即QOV（Quality of Vision）做出贡献，继续成为受社会信赖和需要的企业。 Shuhei Yoshida总裁 经营理念 业务活动 公司简介